IMMU-23. TARGETING THE CD200 CHECKPOINT TO ENHANCE IMMUNOTHERAPY FOR CNS TUMORS

Numerous clinical trials targeting immune checkpoints have failed to enhance survival in patients with CNS tumors. We are targeting a unique checkpoint, CD200, which controls the immune system through paired inhibitory and activation receptors. The CD200 checkpoint interferes with tumor-immune inter...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Moertel, Christopher, Pluhar, G Elizabeth, Ampudia-Mesias, Elisabet, Xiong, Zhengming, Pennell, Christopher A, Rathe, Susan K, Largaespada, David A, Olin, Michael R
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Immunology/Immunotherapy
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6477440/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz036.142
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars